I was talking about yesterdays capitulation. Evidently it was not done.
They still have a candidate but need to reformulate because of the the side effect of diarrhea.
that is a far cry from a drug failure
EAST PALO ALTO, CA--(Marketwired - May 23, 2016) - Finjan Holdings, Inc. (NASDAQ: FNJN), a cybersecurity company, announced that on May 20, 2016, its subsidiary Finjan, Inc. ("Finjan") and Proofpoint, Inc. agreed to a license to the Finjan global patent portfolio. While a settlement has been agreed to, the case dismissal is pending a final definitive licensing and settlement agreement. The terms of the agreement are expected to be confidential, subject to regulatory requirements.